상품명칭: |
Cevane-3,4,6,7,14,15,16,20-octol,4,9-epoxy-, 6,7-diacetate 3-[(2R,3R)-2,3-dihydroxy-2-methylbutanoate]15-[(2R)-2-methylbutanoate], (3b,4a,6a,7a,15a,16b)- |
동의어: |
Neoprotoveratrin; Protoveratrine B (6CI,7CI);Cevane-3,4,6,7,14,15,16,20-octol,4,9-epoxy-, 6,7-diacetate 3-(2,3-dihydroxy-2-methylbutanoate)15-(2-methylbutanoate), [3b(2R,3R),4a,6a,7a,15a(R),16b]-; Veratetrin;Neoprotoveratrine; Cevane-3b,4b,6a,7a,14,15a,16b,20-octol, 4,9-epoxy-, 6,7-diacetate3-[threo-(+)-2,3-dihydroxy-2-methylbutyrate] 15-[(-)-(2R)-methylbutyrate](8CI); NSC 7527; Veratetrine;Cevane-3,4,6,7,14,15,16,20-octol,4,9-epoxy-, 6,7-diacetate 3-[(2R,3R)-2,3-dihydroxy-2-methylbutanoate]15-[(2R)-2-methylbutanoate], (3b,4a,6a,7a,15a,16b)-; |